A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Dexcom Inc stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 23,311 shares of DXCM stock, worth $1.57 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
23,311
Previous 10,620 119.5%
Holding current value
$1.57 Million
Previous $1.47 Million 79.43%
% of portfolio
0.04%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $1.4 Million - $1.78 Million
12,691 Added 119.5%
23,311 $2.64 Million
Q1 2024

May 03, 2024

BUY
$114.22 - $140.1 $358,308 - $439,493
3,137 Added 41.92%
10,620 $1.47 Million
Q4 2023

Feb 09, 2024

SELL
$75.49 - $124.16 $1.1 Million - $1.8 Million
-14,524 Reduced 66.0%
7,483 $929,000
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $1.21 Million - $1.95 Million
14,116 Added 178.89%
22,007 $2.05 Million
Q2 2023

Aug 03, 2023

SELL
$112.47 - $130.98 $5.57 Million - $6.49 Million
-49,526 Reduced 86.26%
7,891 $1.01 Million
Q1 2023

May 12, 2023

BUY
$104.0 - $122.92 $4.43 Million - $5.23 Million
42,573 Added 286.8%
57,417 $6.67 Million
Q4 2022

Feb 13, 2023

SELL
$84.98 - $122.67 $23,199 - $33,488
-273 Reduced 1.81%
14,844 $1.68 Million
Q3 2022

Nov 07, 2022

BUY
$76.35 - $94.18 $106,660 - $131,569
1,397 Added 10.18%
15,117 $1.22 Million
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $816,627 - $1.6 Million
12,011 Added 702.81%
13,720 $1.02 Million
Q1 2022

May 11, 2022

SELL
$94.08 - $130.2 $124,091 - $171,733
-1,319 Reduced 43.56%
1,709 $874,000
Q4 2021

Feb 02, 2022

SELL
$129.87 - $162.82 $799,349 - $1 Million
-6,155 Reduced 67.03%
3,028 $1.63 Million
Q3 2021

Nov 09, 2021

BUY
$106.71 - $143.18 $565,563 - $758,854
5,300 Added 136.49%
9,183 $5.02 Million
Q1 2021

May 10, 2021

SELL
$84.79 - $104.74 $95,727 - $118,251
-1,129 Reduced 22.53%
3,883 $1.4 Million
Q4 2020

Feb 12, 2021

SELL
$78.0 - $104.5 $451,074 - $604,323
-5,783 Reduced 53.57%
5,012 $1.85 Million
Q3 2020

Nov 09, 2020

BUY
$95.51 - $112.95 $199,424 - $235,839
2,088 Added 23.98%
10,795 $4.45 Million
Q2 2020

Aug 05, 2020

BUY
$62.68 - $105.34 $258,993 - $435,264
4,132 Added 90.32%
8,707 $3.53 Million
Q1 2020

May 11, 2020

SELL
$47.79 - $75.63 $127,599 - $201,932
-2,670 Reduced 36.85%
4,575 $1.23 Million
Q4 2019

Mar 19, 2020

BUY
$36.62 - $57.29 $228,911 - $358,119
6,251 Added 628.87%
7,245 $1.59 Million
Q3 2019

Mar 19, 2020

SELL
$35.53 - $43.8 $12,186 - $15,023
-343 Reduced 25.65%
994 $148,000
Q2 2019

Mar 19, 2020

BUY
$27.84 - $38.92 $37,222 - $52,036
1,337 New
1,337 $200,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Bi Asset Management Fondsmaeglerselskab A Portfolio

Follow Bi Asset Management Fondsmaeglerselskab A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.